K-7174 Catalog No.:M8324-2 PubMed PMID: 17336054

PubMed PMID: 17336054

SW033291is a good compound to validate 15-PGDH inhibition could be a new therapeutic strategy for tissue regeneration in diverse clinical contexts

Molecular Weight: 810

and several cancer lineages in vitro

which are both essential for bacterial viability

K-7174 Catalog No.:M8324-2 PubMed PMID: 17336054K 7174 is a novel orally active, potent proteasome inhibitor. K 7174 exerts anti myeloma activity in vitro and in vivo by down regulating the expression of class I histone deacetylases. K 7174 kills bortezomib resistant myeloma cells carrying a 5 subunit mutation in vivo and primary cells from a patient resistant to bortezomib. K 7174 is also a GATA specific inhibitor, which may have potential application in treating anemia of chronic disease. Product